Prevention of neonatal group B streptococcal infections

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Group B streptococcal infections (GBS) are the leading cause of sepsis, pneumonia and meningitis in infants during the first three months of life. GBS infections presenting within the first week of life are designated early-onset diseases, and those affecting infants between one week and three months - late-onset diseases. Intrapartum intravenous administration of antibiotics to women at high risk of transmitting the microorganism to the infants is currently considered the most effective method of prevention of early-onset GBS infections, and universal screening for GBS in late pregnancy - as the most effective method to detect women to whom antibiotic prophylaxis is indicated. Vaccination of pregnant women appears to be a promising approach to prevent both early- and late-onset GBS infections in infants, as well as GBS-associated diseases in women.

Full Text

Restricted Access

About the authors

Elena Vasilyevna Shipitsyna

D. O. Ott Research Institute of Obstetrics and Gynecology, RAMS

Email: shipitsyna@inbox.ru
senior researcher, Laboratory of Microbiology

Alevtina Mikhailovna Savicheva

D. O. Ott Research Institute of Obstetrics and Gynecology, RAMS

Email: savitcheva@mail.ru
head of Laboratory of Microbiology

References

  1. Леонтьева Г. Ф., Суворов А. Н., Мерингова Л. Ф., Грабовская К. Б., Устинович И. А., Тотолян А. А. Экспериментальная оценка рекомбинантных полипептидов как вакцины против стрептококков группы В. Журнал микробиологии, эпидемиологии и иммунобиологии. 2005; 2: 35-40.
  2. Суворов А. Н., Грабовская К. Б., Леонтьева Г. Ф., Мерингова Л. Ф., Королева И. Н., Дуплик Н. В., Тотолян А. А. Рекомбинантные фрагменты консервативных белков стрептококков группы В как основа специфической вакцины. Журнал микробиологии, эпидемиологии и иммунобиологии. 2010; 2: 44-50.
  3. Оганян К. А., Суворов А. Н., Зациорская С. Л., Аржанова О. Н., Осипов К. В., Савичева А. М. Течение и исход беременности при колонизации урогенитального тракта женщин стрептококками группы В, содержащими гены SspB семейства. Журнал акушерства и женских болезней. 2006; LV (2): 47-52.
  4. Тотолян А. А., Суворов А. Н., Дмитриев А. В. Стрептококки группы В в патологии человека. СПб.: Человек, 2009; 112.
  5. Baecher L., Grobman W. Prenatal antibiotic treatment does not decrease group B Streptococcus colonization at delivery. Int J Gynaecol Obstet. 2008; 101: 125-8.
  6. Baker C. J. The spectrum of perinatal group B streptococcal disease. Vaccine. 2013; 31 (Suppl 4): D3-6.
  7. Baker C. J., Kasper D. L. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med. 1976; 294: 753-6.
  8. Baker C. J., Kasper D. L., Edwards M. S. Immunogenicity of polysaccharides from type III, group B Streptococcus. J Clin Invest. 1978; 61: 1107-10.
  9. Baker C. J., Kasper D. L. Group B streptococcal vaccines. Rev Infect Dis. 1985; 7: 458-67.
  10. Baker C.J, Paoletti L. C., Rench M. A., Guttormsen H. K., Carey V. J., Hickman M. E., et al. Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women. J Infect Dis. 2000; 182: 1129-38.
  11. Baker C. J., Paoletti L. C., Rench M. A., Guttormsen H. K., Edwards M. S., Kasper D. L. Immune response of healthy women to two different type V group B streptococcal capsular polysaccharide-protein conjugate vaccines. J Infect Dis 2004; 189: 1103-12.
  12. Baker C. J., Paoletti L. C., Wessels M. R., Guttormsen H. K., Rench M. A., Hickman M. E., Kasper D. L. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis 1999; 179: 142-50.
  13. Baker C. J., Rench M. A., Edwards M. S., Carpenter R. J., Hays B. M., Kasper D. L. Immunization of pregnant women with a polysaccharide vaccine of group B Streptococcus. N Engl J Med. 1988; 319: 1180-5.
  14. Baker C. J., Rench M. A., McInnes P. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine 2003; 21: 3468-72.
  15. Bergeron M. G., Ke D., Ménard C., Picard F. J., Gagnon M., Bernier M., Ouellette M., Roy P. H., Marcoux S., Fraser W. D. Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med. 2000; 343: 175-9.
  16. Bloom S. L., Cox S. M., Bawdon R. E., Gilstrap L. C. Ampicillin for neonatal group B streptococcal prophylaxis: how rapidly can bactericidal concentrations be achieved? Am J Obstet Gynecol. 1996; 175: 974-6.
  17. Boyer K. M., Gotoff S. P. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med. 1986; 314: 1665-9.
  18. Boyer K. M., Gotoff S. P. Strategies for chemoprophylaxis of GBS early-onset infections. Antibiot Chemother. 1985; 35: 267-80.
  19. Brodeur B. R., Boyer M., Charlebois I., Hamel J., Couture F., Rioux C. R., Martin D. Identification of group B streptococcal Sip protein, which elicits cross-protective immunity. Infect Immun 2000; 68: 5610-18.
  20. Castor M. L., Whitney C. G., Como-Sabetti K., Facklam R. R., Ferrieri P., Bartkus J. M., Juni B. A., Cieslak P. R., Farley M. M., Dumas N. B., Schrag S. J., Lynfield R. Antibiotic resistance patterns in invasive group B streptococcal isolates. Infect Dis Obstet Gynecol. 2008; 727505.
  21. Centers for Disease Control and Prevention. Prevention of perinatal Group B streptococcal disease. Revised guidelines from CDC, 2010. MMWR. 2010; 59 (RR-10): 1-36.
  22. Cutland C. L., Madhi S. A., Zell E. R., Kuwanda L., Laque M., Groome M., Gorwitz R., Thigpen M. C., Patel R., Velaphi S. C., Adrian P., Klugman K., Schuchat A., Schrag S. J.; PoPS Trial Team. Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet. 2009; 374 (9705): 1909-16.
  23. Davies H. D., Miller M. A., Faro S., Gregson D., Kehl S. C., Jordan J. A. Multicenter study of a rapid molecular-based assay for the diagnosis of group B streptococcus colonization in pregnant women. Clin Infect Dis. 2004; 39: 1129-1135.
  24. Desa D. J., Trevenen C. L. Intrauterine infections with group B beta-haemolytic streptococci. Br J Obstet Gynaecol. 1984; 91: 237-9.
  25. Dillon H. C., Khare S., Gray B. M. Group B streptococcal carriage and disease: a 6-year prospective study. J Pediatr. 1987; 110: 31-6.
  26. Di Renzo G. C., Melin P., Berardi A., Blennow M., Carbonell-Estrany X., Donzelli G. P., Hakansson S., Hod M., Hughes R., Kurtzer M., Poyart C., Shinwell E., Stray-Pedersen B., Wielgos M., El Helali N. Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference J Matern Fetal Neonatal Med. 2014; 27: 1-17.
  27. Edmond K. M., Kortsalioudaki C., Scott S., Schrag S. J., Zaidi A. K., Cousens S., Heath P. T. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet. 2012; 379 (9815): 547-56.
  28. Faxelius G., Bremme K., Kvist-Christensen K., Christensen P., Ringertz S. Neonatal septicemia due to group B streptococci - perinatal risk factors and outcome of subsequent pregnancies. J Perinat Med. 1988; 16: 423-30.
  29. Gagneur A., Héry-Arnaud G., Croly-Labourdette S., Gremmo-Feger G., Vallet S., Sizun J., Quentin R., Tandé D. Infected breast milk associated with late-onset and recurrent group B streptococcal infection in neonatal twins: a genetic analysis. Eur J Pediatr. 2009; 168: 1155-8.
  30. Gardner S. E., Yow M. D., Leeds L. J., Thompson P. K., Mason E. O. Jr, Clark D. J. Failure of penicillin to eradicate group B streptococcal colonization in pregnant women: a couple study. Am J Obstet Gynecol. 1979; 135 (8): 1062-5.
  31. Garland S. M., Fliegner J. R. Group B Streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis. Aust N Z J Obstet Gynaecol. 1991; 31: 119-22.
  32. Gavino M., Wang E. A comparison of a new rapid real-time polymerase chain reaction system to traditional culture in determining group B Streptococcus colonization. Am J Obstet Gynecol. 2007; 197: 388e1-4.
  33. Gibson R. L., Soderland C., Henderson W. R. Jr. Group B streptococci (GBS) injure lung endothelium in vitro: GBS invasion and GBS-induced eicosanoid production is greater with microvascular than with pulmonary artery cells. Infect. Immun. 1995; 63: 271-9.
  34. Haberland C.A, Benitz W. E., Sanders G. D., Pietzsch J. B., Yamada S., Nguyen L., Garber A. M. Perinatal screening for Group B streptococci: cost-benefit analysis of rapid polymerase chain reaction. Pediatrics. 2002; 110: 471-80.
  35. Hager W. D., Schuchat A., Gibbs R., Sweet R., Mead P., Larsen J. W. Prevention of perinatal group B streptococcal infection: current controversies. Obstet Gynecol. 2000; 96: 141-5.
  36. Heath P. T., Balfour G., Weisner A. M., Efstratiou A., Lamagni T. L., Tighe H., O'Connell L. A., Cafferkey M., Verlander N. Q., Nicoll A., McCartney A. C.; PHLS Group B Streptococcus Working Group. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet. 2004; 363 (9405): 292-4.
  37. Heath P. T., Schuchat A. Perinatal group B streptococcal disease. Best Pract Res Clin Obstet Gynaecol. 2007; 21: 411-24.
  38. Honest H., Sharma S., Khan K. S. Rapid tests for group B Streptococcus colonization in laboring women: a systematic review. Pediatrics. 2006; 117 (4): 1055-66.
  39. Johri A. K., Paoletti L. C., Glaser P., Dua M., Sharma P. K., Grandi G., Rappuoli R. Group B streptococcus: global incidence and vaccine development. Nat Rev Microbiol. 2006; 4: 932-42.
  40. Katz V., Bowes W. A. Jr. Perinatal group B streptococcal infections across intact amniotic membranes. J Reprod Med. 1988; 33: 445-9.
  41. Kreikemeyer B., Gamez G., Margarit I., Giard J. C., Hammerschmidt S., Hartke A., Podbielski A. Genomic organization, structure, regulation and pathogenic role of pilus constituents in major pathogenic Streptococci and Enterococci. Int J Med Microbiol. 2011; 301: 240-51.
  42. Lim D. V., Morales W. J., Walsh A. F., Kazanis D. Reduction of morbidity and mortality rates for neonatal group B streptococcal disease through early diagnosis and chemoprophylaxis. J Clin Microbiol. 1986; 23: 489-92.
  43. Lin F. Y. C., Weisman L. E., Troendle J., Adams K. Prematurity is the major risk factor for late-onset group B streptococcus disease. J Infect Dis. 2003; 15; 188 (2): 267-71.
  44. Madhi S. A., Dangor Z., Heath P. T., Schrag S., Izu A. Sobanjo-Ter Meulen A., Dull P. M. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. Vaccine. 2013; 31 (Suppl 4): D52-7.
  45. Margarit I., Rinaudo C. D., Galeotti C. L., Maione D., Ghezzo C., Buttazzoni E., Rosini R., Runci Y., Mora M., Buccato S., Pagani M., Tresoldi E., Berardi A., Creti R., Baker C. J., Telford J. L., Grandi G. Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. J Infect Dis. 2009; 199: 108-15.
  46. Matorras R., Garca-Perea A., Omeaca F., Diez-Enciso M., Madero R., Usandizaga J. A. Intrapartum chemoprophylaxis of early-onset group B streptococcal disease. Eur J Obstet Gynecol Reprod Biol. 1991; 40: 57-62.
  47. Melin P. Group B Streptococcal disease in the newborn - maternal screening methods and antimicrobial prophylaxis. Eur Obst & Gyn 2008; 3: 58-62.
  48. Melin P. Neonatal group B streptococcal disease: from pathogenesis to preventive strategies. Clin Microbiol Infect. 2011; 17: 1294-303.
  49. Money D., Allen V. M.; Society of Obstetrician and Gynaecologists of Canada. The prevention of early-onset neonatal group B streptococcal disease. J Obstet Gynaecol Can. 2013; 35 (10): 939-51.
  50. Money D., Dobson S., Cole L., Karacabeyli E., Blondel-Hill E,. Milner R., Thomas E. An evaluation of a rapid real time polymerase chain reaction assay for detection of group B Streptococcus as part of a neonatal group B Streptococcus prevention strategy. J Obstet Gynaecol Can. 2008; 30: 770-5.
  51. Nizet V. Molecular pathogenesis of group B streptococcal disease in newborns. In: Stevens DL, Kaplan EL, eds. Streptococcal infections. New York: Oxford University Press, 2000; 180-221.
  52. Paoletti L. C., Guttormsen H. K., Christian M. S., Hoberman A. M., McInnes P. Neither antibody to a group B streptococcal conjugate vaccine nor the vaccine itself is teratogenic in rabbits. Human Vaccines. 2008; 4 (6): 435-43.
  53. Phares C. R., Lynfield R., Farley M. M., Mohle-Boetani J., Harrison L. H., Petit S., Craig A. S., Schaffner W., Zansky S. M., Gershman K., Stefonek K. R., Albanese B. A., Zell E. R., Schuchat A., Schrag S. J.; Active Bacterial Core surveillance/Emerging Infections Program Network. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA. 2008; 299: 2056-65.
  54. Poyart C., Reglier-Poupet H., Tazi A., Billoët A., Dmytruk N., Bidet P., Bingen E., Raymond J., Trieu-Cuot P. Invasive Group B streptococcal infections in infants, France. Emerg Infect Dis. 2008; 14: 1647-9.
  55. Puopolo K. M., Madoff L. C., Eichenwald E. C. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics. 2005; 115: 1240-6.
  56. Ramus R. M., McIntire D. D., Wendel G. D. Jr. Antibiotic chemoprophylaxis for group B strep is not necessary with elective cesarean section at term. Am J Obstet Gynecol. 1999; 180: S85.
  57. Saleem S., Rouse D., McClure E., Zaidi A., Reza T., Yahya Y., Memon I. A., Khan N. H., Memon G., Soomro N., Pasha O., Wright L. L., Moore J., Goldenberg R. L. Chlorhexidine vaginal and infant wipes to reduce perinatal mortality and morbidity: a randomized controlled trial. Obstet Gynecol. 2010; 115: 1225-32.
  58. Schofield F. D., Tucker V. M., Westbrook G. R. Neonatal tetanus in New Guinea. Effect of active immunization in pregnancy. Br Med J. 1961; 2 (5255): 785-9.
  59. Schrag S. J., Verani J. R. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine. 2013; 31 (Suppl 4): D20-6.
  60. Schrag S. J., Zell E. R., Lynsfield R., Roome A., Arnold K. E., Craig A. S., Harrison L. H., Reingold A., Stefonek K., Smith G., Gamble M., Schuchat A.; Active Bacterial Core Surveillance Team. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med. 2002; 347: 233-9.
  61. Schrag S. J., Zywicki S., Farley M. M., Reingold A. L., Harrison L. H., Lefkowitz L.B, Hadler J. L., Danila R., Cieslak P. R., Schuchat A. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000; 342: 15-20.
  62. Schuchat A. Group B streptococcus. Lancet. 1999; 353: 51-6.
  63. Stoll B. J., Schuchat A. Maternal carriage of group B streptococci in developing countries. Pediatr Infect. Dis J. 1998; 17: 499-503.
  64. Telford J. L., Barocchi M. A., Margarit I., Rappuoli R., Grandi G. Pili in Gram-positive pathogens. Nature Rev Microbiol. 2006; 4: 509-19.
  65. Trijbels-Smeulders M. A. J.M., Kolee L. A. A., Adriaanse A. H., Kimpen J. L. L., Gerards L. J. Neonatal group B streptococcal infection: incidence and strategies for prevention in Europe. Pediatr Infect Dis J. 2004; 23: 172-3.
  66. Tuppurainen N., Hallman M. Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients. Obstet Gynecol. 1989; 73: 583-7.
  67. Van Dyke M. K., Phares C. R., Lynfield R., Thomas A. R., Arnold K. E., Craig A. S., Mohle-Boetani J., Gershman K., Schaffner W., Petit S., Zansky S. M., Morin C. A., Spina N. L., Wymore K., Harrison L. H., Shutt K. A., Bareta J., Bulens S. N., Zell E. R., Schuchat A., Schrag S. J. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med. 2009; 360: 2626-36.
  68. Verani J. R., Schrag S. J. Group B streptococcal disease in infants: progress in prevention and continued challenges. Clin Perinatol. 2010; 37: 375-92.
  69. Wood E. G., Dillon H. C. Jr. A prospective study of group B streptococcal bacteriuria in pregnancy. Am J Obstet Gynecol. 1981; 140 (5): 515-20.
  70. Yancey M. K., Schuchat A., Brown L. K., Ventura V. L., Markenson G. R. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol. 1996; 88: 811-5.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Shipitsyna E.V., Savicheva A.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 66759 от 08.08.2016 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия Эл № 77 - 6389 от 15.07.2002 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies